Top Story

Immediate access to opioid agonist treatment could save billions

November 20, 2017

Read the Perspective from Lawrence Greenblatt, MD, FACP

Unlimited, immediate access to opioid agonist treatment with methadone for patients with opioid use disorder offers drastic cost savings and greater health benefits compared with the standard of care, according to a study published in Annals of Internal Medicine.

Limited access to opioid agonist treatment with either methadone or buprenorphine is a major impediment to reducing the societal burden of the current prescription opioid and heroin use epidemic,” Emanuel Krebs, MA, from British Columbia Centre for Excellence in HIV/AIDS, Canada, and colleagues wrote.

FDA News

FDA accepts NDA for dasotraline for ADHD

November 20, 2017
Sunovion Pharmaceuticals Inc. recently announced the FDA accepted for review a New Drug Application for dasotraline, a novel-acting dopamine and norepinephrine reuptake…

HSS highlights recent progress against antibiotic resistance

November 17, 2017
As part of World Antibiotic Awareness Week, HHS has released a progress report summarizing achievements made during the first 2 years of implementing a national strategy…

AGA campaign aims to educate patients on GI risks of OTC pain meds

November 17, 2017
The American Gastroenterological Association created the Gut Check: Know Your Medicine campaign to help educate patients on how to safely use over-the-counter pain…
More Headlines »

Ace the Case: A 39-Year-Old Man with Progressive Weight Gain

No commercial support for this activity.

This “Ace the Case” activity will use a case study to discuss obesity management in a patient with progressive weight…
More »
GI Bookshelf

Chapter 5: Dysplasia And Colorectal Cancer

From Clinical Challenges and Complications of IBD
More »
Resource Centers
American Heart Association Scientific Sessions

American Heart Association Scientific Sessions

Meeting News Coverage

VIDEO: Drappa discusses anifrolumab for patients with SLE

February 25, 2016
More »